February 27, 2015 6:08 PM ET


Company Overview of G2 Therapies Pty Limited

Company Overview

G2 Therapies Pty Limited, a biotechnology company, specializes in developing and commercializing of monoclonal antibody based therapies in inflammation and cancer areas. Its clinical development product includes a humanised antibody therapeutic for inflammatory diseases, such as rheumatoid arthritis. The company was incorporated in 2000 and is based in Darlinghurst, Australia.

Level 10

384 Victoria Street

Darlinghurst, NSW 2010


Founded in 2000


61 2 9295 8402


61 2 9295 8404

Key Executives for G2 Therapies Pty Limited

Chief Executive Officer
Co-Founder, CSO and Director
Co-Founder and Director
General Manager and Company Secretary
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Medi-Stream Pty Limited Asia
Panvax Ltd. Asia
Aquaceutics Pty Ltd Asia
Ilexus Pty Ltd. Asia
Vaxxas Pty. Ltd. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact G2 Therapies Pty Limited, please visit www.g2therapies.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.